The Recall Desk
HighFDA (Devices)·Z-0517-2024·Announced 2023-12-20

Brachytherapy Treatment Planning Software Recalled Due to Measurement Inaccuracy

SagiPlan 2.2 brachytherapy treatment planning software is recalled due to a software malfunction that may round numerical values, potentially causing inaccurate treatment measurements.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is a Class II FDA medical device recall affecting a safety-critical radiation therapy planning system. The software malfunction could result in inaccurate treatment measurements, but no illnesses or injuries have been reported. Per the rubric, high-risk products where injury has not yet been reported receive a score of 3.

Plain-English summary

SagiPlan 2.2 is a brachytherapy treatment planning system manufactured by Bebig Isotopentechnik GmbH. The software is used to plan and calculate radiation therapy treatments.

A software malfunction has been identified that may cause numerical values to be rounded. When values are rounded, the resulting treatment measurements may be inaccurate.

Two licenses of this software are distributed and in use in the United States. An additional 255 licenses are distributed internationally, primarily in Germany. This recall was issued by the FDA and assigned notice number Z-0517-2024 with a Class II classification.

The recalled product

Product
SagiPlan 2.2, CE0344, Rx Only , Brachyterapy Treatment Planning System
Manufacturer
Bebig Isotopentechnik Gmbh
Hazard
  • software-malfunction
  • measurement-error

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • SagiPlan
  • article # 1374-0600
  • version 2.2

Distribution

Distributed in 1 state:

  • MD